Involvement of circulating CEA in liver metastases from colorectal cancers re-examined in a new experimental model
1999
Role of CEA in Liver Metastases from Colorectal Cancer
Sample size: 3
publication
Evidence: moderate
Author Information
Author(s): Leconte A, Garambois V, Ychou M, Robert B, Pourquier D, Terskikh A, Mach J P, Pèlegrin A
Primary Institution: Centre de Recherche en Cancérologie, CRLC Val d'Aurelle – Paul Lamarque Cancer Centre
Hypothesis
Does circulating CEA facilitate liver metastases in colorectal cancer?
Conclusion
The study found that circulating CEA levels do not influence the number or size of liver metastases from colorectal cancer.
Supporting Evidence
- Elevated blood levels of CEA correlate with liver metastases in colorectal cancer.
- A new experimental model was developed to study the role of CEA.
- The study showed that circulating CEA levels do not affect liver metastasis size or number.
Takeaway
This study looked at whether a substance called CEA in the blood helps cancer spread to the liver, and it found that it doesn't.
Methodology
The researchers used a new experimental model with different clones of colon cancer cells to study the effects of CEA on liver metastases.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website